WO2007058505A1 - Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same - Google Patents
Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same Download PDFInfo
- Publication number
- WO2007058505A1 WO2007058505A1 PCT/KR2006/004871 KR2006004871W WO2007058505A1 WO 2007058505 A1 WO2007058505 A1 WO 2007058505A1 KR 2006004871 W KR2006004871 W KR 2006004871W WO 2007058505 A1 WO2007058505 A1 WO 2007058505A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hangover
- red pepper
- raw
- weight
- alcohol
- Prior art date
Links
- 206010019133 Hangover Diseases 0.000 title claims abstract description 141
- 229940077082 red pepper extract Drugs 0.000 title claims abstract description 71
- 235000013305 food Nutrition 0.000 title claims description 12
- 230000036541 health Effects 0.000 title claims description 5
- 239000003795 chemical substances by application Substances 0.000 title description 2
- 230000000694 effects Effects 0.000 claims abstract description 31
- 235000013402 health food Nutrition 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 240000004160 Capsicum annuum Species 0.000 claims description 53
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims description 53
- 235000007862 Capsicum baccatum Nutrition 0.000 claims description 53
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 26
- 235000013361 beverage Nutrition 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 23
- 239000001728 capsicum frutescens Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- 239000006000 Garlic extract Substances 0.000 claims description 15
- 235000020706 garlic extract Nutrition 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 15
- 239000007791 liquid phase Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 12
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000004821 distillation Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 4
- 240000006891 Artemisia vulgaris Species 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 235000019260 propionic acid Nutrition 0.000 claims description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 155
- 230000035622 drinking Effects 0.000 abstract description 35
- 235000013334 alcoholic beverage Nutrition 0.000 abstract description 10
- 230000009467 reduction Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 61
- 239000008280 blood Substances 0.000 description 51
- 210000004369 blood Anatomy 0.000 description 51
- 208000024891 symptom Diseases 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 18
- 230000036772 blood pressure Effects 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 16
- 229940079593 drug Drugs 0.000 description 14
- 239000003814 drug Substances 0.000 description 14
- 230000002159 abnormal effect Effects 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 239000002994 raw material Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000007689 inspection Methods 0.000 description 9
- 230000008673 vomiting Effects 0.000 description 9
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 8
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 8
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 8
- 206010047700 Vomiting Diseases 0.000 description 8
- 238000004806 packaging method and process Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 206010019233 Headaches Diseases 0.000 description 7
- 238000007792 addition Methods 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 230000003908 liver function Effects 0.000 description 7
- 235000019997 soju Nutrition 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 5
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000003494 hepatocyte Anatomy 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 108010082126 Alanine transaminase Proteins 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 4
- 206010019708 Hepatic steatosis Diseases 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 208000010706 fatty liver disease Diseases 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000902 placebo Substances 0.000 description 4
- 229940068196 placebo Drugs 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 231100000240 steatosis hepatitis Toxicity 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 108010033145 microsomal ethanol-oxidizing system Proteins 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- LPLLVINFLBSFRP-UHFFFAOYSA-N 2-methylamino-1-phenylpropan-1-one Chemical compound CNC(C)C(=O)C1=CC=CC=C1 LPLLVINFLBSFRP-UHFFFAOYSA-N 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 244000293323 Cosmos caudatus Species 0.000 description 2
- 235000005956 Cosmos caudatus Nutrition 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000015197 apple juice Nutrition 0.000 description 2
- 239000012237 artificial material Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000036765 blood level Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 238000012812 general test Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 235000015205 orange juice Nutrition 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000027205 Congenital disease Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010061164 Gastric mucosal lesion Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000021191 food habits Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000020803 food preference Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 231100000149 liver necrosis Toxicity 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004065 mitochondrial dysfunction Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/105—Natural spices, flavouring agents or condiments; Extracts thereof obtained from liliaceae, e.g. onions, garlic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/115—Natural spices, flavouring agents or condiments; Extracts thereof obtained by distilling, stripping, or recovering of volatiles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a hangover cure containing a raw red pepper extract and a health food containing the same. More specifically, the present invention relates to a hangover cure containing a raw red pepper extract, which is effective for prevention and relief of alcohol-induced hangovers, and which can be easily taken via addition thereof to alcoholic beverages, or can be conveniently taken before and/or after alcohol drinking; and a health food containing the same.
- Alcohols which are not stored in tissues unlike other foodstuffs, are oxidized into acetaldehyde by catalytic action of alcohol dehydrogenase (ADH), largely in the liver, and when metabolism progresses further, the resulting acetaldehyde is broken down into acetic acid and H by catalytic action of aldehyde dehydrogenase (ALDH) (Jae-Youl Cho, et al., Korean Journal of Food Science & Technology, 29 (1), 167-172 (1997)). 90% of the thus-formed acetic acid is directly converted into CO and H O, and the remaining 10% thereof is completely degraded via TCA cycle (Jae-Youl Cho, et al.; Lieber CS.
- ADH alcohol dehydrogenase
- MEOS microsomal ethanol oxidizing system
- acetaldehyde known as a primary cause of hangovers, exhibits high affinity for sulfur-containing materials including cysteine and glutathione, in liver microsomes, and induces changes in the lipid composition of plasma membranes, thereby causing liver damage such as fatty liver and liver necrosis (Kaufman N. et al., AM. A. Arch. Path 70, 331 (I960)).
- alcohols Depending upon intake amounts, alcohols exhibit various effects on the body. For example, intake of large amounts of alcohols within a short period of time results in accumulation of aldehyde in conjunction with the accompanying symptoms such as vomiting, headache, lowering of blood pressure, tachycardia and shock, and particularly interferes with lipid oxidation in the liver or drug metabolism in the endoplasmic reticulum. Chronic ingestion of alcohols induces adaptability which results in increased metabolism of alcohols and drugs and accelerates production of lipoproteins, thereby leading to damage of hepatocytes (Rosser B. G. and Gores GJ., Gastroenterology, 108, 252 (1995)).
- the present invention has been made in view of the above problems, and it is an object of the present invention to provide a hangover cure which is effective for prevention and relief of alcohol hangovers, and which can be easily taken via addition thereof to alcoholic beverages, or can be conveniently taken before and/or after alcohol drinking.
- a hangover cure comprising a raw red pepper extract as an active ingredient.
- the hangover cure according to the present invention has alcohol hangover- relieving effects such as reduction of an alcohol concentration, and can be easily taken via addition thereof to alcoholic beverages, or can be conveniently taken before and/or after alcohol drinking.
- FIG. 1 is a graph showing the analysis results of GS-Mass Spectrometry for addition of sample E at a 2% concentration, as a representative example according to the present invention
- FIG. 2 is a graph showing a calibration curve for experimental data obtained from
- FIG. 3 is a graph showing comparison results of blood alcohol concentrations with a varying blood-collecting period of time, after alcohol was drunk by a group which had ingested a hangover cure according to the present invention and a control group, respectively;
- FIG. 4 is a graph showing comparison results of blood alcohol concentrations with a varying blood-collecting period of time, after alcohol was drunk by a group which had ingested a hangover cure extracted according to another method of the present invention and a control group, respectively.
- red peppers (8-methyl-N-vanillyl-6-nonenamide) which is known to facilitate secretion of gastric juices, thereby resulting in improvement of appetite, and have blood-circulation promoting effects.
- red peppers are known to exhibit muco-kinetic action which dilutes the mucus and allows for easy excretion of phlegm, and exert analgesic action via temporal sensory neuron blocking effects.
- excessive intake of red peppers irritates the gastrointestines and thereby results in gastric mucosal lesions, diarrhea and hepatic insufficiency.
- the hangover cure of the present invention contains a raw red pepper (including both unripe and ripe red peppers) extract as an active ingredient.
- a content of the raw red pepper extract is not particularly limited and the hangover cure may contain, for example 2 to 100% by weight of the raw red pepper extract, based on the total weight of the hangover cure. That is, the raw red pepper extract per se may be used as the hangover cure or otherwise may be used as the hangover cure in combination with other ingredients such as water, beverage ingredients and the like.
- the remaining ingredients other than the raw red pepper extract may be composed of water.
- the hangover cure of the present invention may contain pyroligneous liquor.
- the pyroligneous liquor serves to prevent alteration of the hangover cure of the present invention.
- an amount of the pyroligneous liquor added it is preferred to add the pyroligneous liquor in an amount of 0.5 to 5% by weight, based on the total weight of the hangover cure.
- the pyroligneous liquor that can be used in the present invention may be composed of 2 to 4% by weight of acetic acid, 0.05 to 0.15% by weight of formic acid, 0.05 to 0.15% by weight of propionic acid, 1 to 3% by weight of mugwort components, 0.01 to 1% by weight of sodium acetate (or zinc sulfate), and the balance of purified water.
- the hangover cure of the present invention may further contain a garlic extract.
- the garlic extract is added as an auxiliary substance to assist in relief of the hangover. Therefore, use of the garlic extract in conjunction with the raw red pepper extract results in synergistic hangover-relieving effects.
- An added amount of the garlic extract may be preferably in a range of 0.5 to 10% by weight without being limited thereto, based on the total weight of the hangover cure.
- the hangover cure of the present invention may be provided in the form of capsules, tablets or health drinks.
- the hangover cure may also be in the form of health foods containing the above hangover cure as an active ingredient, for example including various forms such as tea, jelly, sap, juice, extract, beverage and other favorite foods.
- the content of the hangover cure may be, without limitation, in the range of 0.1 to 20% by weight.
- the hangover cure or beverage of the present invention may optionally contain herbal medicine components such as ginseng ingredients, or various vitamins or minerals, citric acid, sodium citrate, malic acid, lecithin, lactic acid, amino acid, sugar, honey, fructose, natural flavors, natural pigments and the like, as food additives known in the art.
- herbal medicine components such as ginseng ingredients, or various vitamins or minerals, citric acid, sodium citrate, malic acid, lecithin, lactic acid, amino acid, sugar, honey, fructose, natural flavors, natural pigments and the like, as food additives known in the art.
- the raw red pepper extract which is utilized in the hangover cure of the present invention, may be obtained by squeezing the juice of red peppers, followed by distillation.
- the red pepper extract may be prepared according to the following extraction process. That is, the process includes the steps of:
- Red peppers begin to bear fruits from early summer. Such green fruits are called unripe red peppers. When red peppers are allowed to grow without collection of fruits, the green fruits turn into red colored fruits, called ripe red peppers, around the middle of August. The time of changing from unripe green color to ripe red color is not constant while showing variations depending upon cultivation techniques and regions. Generally, unripe red pepper fruits may be harvested about 15 days after blooming, and 50 days later, ripe red fruits may be harvested. According to the present invention, as will be illustrated hereinafter, the unripe and ripe red peppers may be used separately or in combination thereof because both of them exhibit almost the same effects on alleviation of alcohol hangovers.
- the squeezed juice is heated to a temperature range of 50 to 11O 0 C and the resulting steam is passed through a cooling device, followed by collecting the condensed liquid to obtain a distillate. More preferably, the squeezed juice is heated to 80 to 9O 0 C.
- distillation of the squeezed juice in the above temperature range leads to co-existence of active ingredients (such as as- paraginie, aspartic acid and the like) of red peppers in the resulting trace distillate by azeotropy.
- the squeezed juice is preferably heated at a temperature of 90 to 11O 0 C with stirring until no formation of bubbles occurs.
- a heating period of time usually takes about 30 min. Heating of the squeezed juice in the above temperature range enables better elution of active ingredients contained in red peppers.
- the heating step is conducted at a temperature of 100 to 11O 0 C.
- a liquid phase is formed as a top layer, while aggregates are formed as a bottom layer.
- the liquid layer corresponding to the top layer fraction is collected from two separated layers, and is then condensed by distillation.
- the liquid layer is heated to a temperature range of 70 to
- distillation of the liquid layer in the above temperature range leads to co-existence of active ingredients (such as capsaicin) of red peppers in the resulting distillate by azeotropy. More preferably, the liquid layer fraction is heated to 90 to 115 0 C.
- the method for preparing the raw red pepper extract may further include filling the filtrate in a brown glass bottle container and sterilizing the contents at a temperature of 80 to 9O 0 C for 10 to 20 min.
- the reason why the brown glass bottle is used upon filling thereof is to prevent oxidation of the extract due to direct or indirect exposure thereof to UV light. Therefore, among brown glass bottles, it is preferred to use those to which UV-blocking pigments were incorporated. Where sterilization of the contents of the bottle is performed outside the above-mentioned conditions, it is difficult to sufficiently achieve desired sterilization effects or it may disadvantageously result in undesirable effects on characteristics of the products.
- the extract according to the present invention may be used as a beverage as it is, or may be otherwise prepared into a beverage formulation via combination with other beverage components.
- 0.1 to 20% by weight of the extract is combined to be incorporated into the beverage.
- the beverage may be composed of 0.1 to 20% by weight of the extract of the present invention and the balance of water.
- the hangover cure of the present invention can be drunk via addition thereof to alcohols, upon intake of alcoholic liquors, or can be directly taken before and/or after alcohol drinking.
- a dose of the hangover cure may vary depending upon intake amounts of alcohols, body weight, sex and liver functions of subjects.
- the dose of the hangover cure is excessively low, i.e., below 1 g, it is impossible to achieve hangover-relieving effects as desired. In contrast, if the dose of the hangover cure exceeds 1O g, this may result in gastric irritation.
- the hangover cure of the present invention is administered in admixture with an alcoholic beverage, it is preferred to add the hangover cure in a ratio of 0.5 to 5 vol% to the alcoholic beverage.
- Example 1 Preparation of raw unripe red pepper extract
- the top layer (a liquid phase) was collected from the separated two layers, heated to 11O 0 C using a vacuum extractor (COSMOS 660, KyungSeo Machine Co., Inchon, Korea), while passing the evolving steam through a cooling tower, followed by collecting the condensed transparent liquid.
- COSMOS 660 KyungSeo Machine Co., Inchon, Korea
- the condensed transparent distillate liquid was subjected to filtration under reduced pressure, using a fiber filter having a pore size of 1 D.
- a fiber filter having a pore size of 1 D After inspection of the thus-obtained filtrate under standards specified by Food Sanitation Law, only the liquid phase of the raw materials which has satisfied the specified standard requirements was selected.
- Predetermined amounts of the liquid phase suitable for specified standard requirements were respectively filled in containers, followed by packaging.
- Packaged containers were sterilized at 8O 0 C for 10 min.
- the sterilized containers were labeled, indicated with the date of manufacture and wrapped in standard packaging boxes, thereby finishing manufacture of products. Products thus produced were colorless red pepper stock solutions and their characteristics were free of off-taste and off- flavor.
- the results of quality inspection test for products are given in Table 1 below.
- Red pepper extracts were prepared in the same manner as in Example 1, except that raw ripe red peppers, matured about 50 days after blooming, were used as raw materials, instead of domestic raw unripe red peppers in Example 1.
- the pyroligneous liquor used herein was prepared according to a method disclosed in Korean Patent Application No. 2005-0098620, assigned to the present applicant. More specifically, the procedure for preparing the pyroligneous liquor will be described in more detail as follows. 600 g of crude pyroligneous liquor was introduced into a round bottom flask to which 2 g of 80% phosphoric acid was then added. Thereafter, the flask was equipped with a cooling condenser, and 24 g of 30% aqueous hydrogen peroxide was gradually added to the crude pyroligneous liquor. The resulting mixture was reacted for 8 hours by heating it to 7O 0 C with stirring at 110 rpm.
- the thus-obtained pyroligneous liquor was composed of 2 to 4% by weight of acetic acid, 0.05 to 0.15% by weight of formic acid, 0.05 to 0.15% by weight of propionic acid, 1 to 3% by weight of mugwort components, 0.01 to 1% by weight of sodium acetate and the balance of purified water.
- a hangover cure was prepared in the same manner as in Example 3, except that the raw ripe red pepper extract obtained in Example 2 was used, and 3% by weight of purified pyroligneous liquor was added based on the total weight of the extract.
- Example 1 Based on the total weight of the extract, 5% by weight of a garlic extract was added to the raw unripe red pepper extract obtained in Example 1, thereby preparing a hangover cure.
- the garlic extract was prepared in the same manner as in Example 1, except that garlic was used as a raw material.
- a hangover cure was prepared in the same manner as in Example 5, except that the raw unripe red pepper extract obtained in Example 2 was used, and 8% by weight of a garlic extract was added based on the total weight of the extract.
- Example 8 Preparation of raw ripe red pepper extract
- Red pepper extracts were prepared in the same manner as in Example 7, except that raw ripe red peppers, matured about 50 days after blooming, were used as raw materials, instead of domestic raw unripe red peppers in Example 7.
- the pyroligneous liquor used herein was prepared according to a method disclosed in Korean Patent Application No. 2005-0098620, assigned to the present applicant. More specifically, the procedure for preparing the pyroligneous liquor will be described in more detail as follows. 600 g of crude pyroligneous liquor was introduced into a round bottom flask to which 2 g of 80% phosphoric acid was then added. Thereafter, the flask was equipped with a cooling condenser, and 24 g of 30% aqueous hydrogen peroxide was gradually added to the crude pyroligneous liquor. The resulting mixture was reacted for 8 hours by heating it to 7O 0 C with stirring at 110 rpm.
- the thus-obtained pyroligneous liquor composed of 2 to 4% by weight of acetic acid, 0.05 to 0.15% by weight of formic acid, 0.05 to 0.15% by weight of propionic acid, 1 to 3% by weight of mugwort components, 0.01 to 1% by weight of sodium acetate and the balance of purified water.
- a hangover cure was prepared in the same manner as in Example 9, except that the raw ripe red pepper extract obtained in Example 8 was used, and 3% by weight of purified pyroligneous liquor was added based on the total weight of the extract.
- Example 11 Preparation of raw unripe red pepper extract and garlic extract mixture
- Example 7 Based on the total weight of the extract, 5% by weight of a garlic extract was added to the raw unripe red pepper extract obtained in Example 7, thereby preparing a hangover cure.
- the garlic extract was prepared in the same manner as in Example 7, except that garlic was used as a raw material.
- Example 12 Preparation of raw ripe red pepper extract and garlic extract mixture
- a hangover cure was prepared in the same manner as in Example 11, except that the raw ripe red pepper extract obtained in Example 8 was used, and 8% by weight of a garlic extract was added based on the total weight of the extract.
- Example 13 Effects of red pepper extract on alcohol concentration [113] Using the red pepper extract obtained in Example 1 as a sample, a test for alcohol concentration-reducing effects thereof was repeatedly carried out four times: Sample A, once; Sample B, twice; Sample D, thrice; and Sample E, four times. In addition, using the raw ripe red pepper extract obtained in Example 2 as a sample, a test for alcohol concentration-reducing effects of the extract (Sample F) was carried out. The same test was also conducted for the sample to which the pyroligneous liquor obtained in Example 3 was added (Sample C). The tests were performed by the Institute of Environment of Kyunggi University (Seoul, Korea). Test methods are as follows.
- FIG. 1 is a graph showing the analysis results of GS-Mass Spectrometry for addition of sample E at a 2% concentration, as a representative example according to the present invention
- FIG. 2 is a graph showing a calibration curve for experimental data obtained from GS-Mass Spectrometry, in conjunction with data prior to conversion thereof into % values.
- Example 14 Effects of red pepper extract on alcohol concentration [121] Using the raw unripe red pepper extract obtained in Example 7 as a sample, a test for alcohol concentration-reducing effects thereof was repeatedly carried out three times: Sample G, once; Sample H, twice; and Sample J, thrice. In addition, using the raw ripe red pepper extract obtained in Example 8 as a sample, a test for alcohol concentration-reducing effects of the extract (Sample K) was carried out. The same test was also conducted for the sample to which the pyroligneous liquor obtained in Example 9 was added (Sample I). The tests were performed by the Institute of Environment of Kyunggi University (Seoul, Korea). Test methods are as follows.
- Example 1 Using the red pepper extract obtained in Example 1 as a sample, a clinical test for hangover-relieving effects thereof on humans was carried out. The test was performed by Dept. of Preventive Medicine Yonsei Univ. Wonju College of Medicine (Wonju, Korea).
- Alcohol hangovers refer to the aftereffects following the consumption of large amounts of alcoholic beverages, which are accompanied by headaches, diarrhea, anorexia, nausea, vomiting and the like. Alcohol hangovers are caused by various factors including dehydration, toxicity of alcohols and metabolites thereof, and malabsorption. For objective evaluation of subjective symptoms in this test, determination of blood alcohol concentrations and other clinical examinations were conducted.
- Test material and placebo single dosage forms of test products (20 mL)
- NADH nicotinamide- adenine dinucleotide
- liver function values of subjects [222] Blood SGPT(ALT), SGOT(AST) and ⁇ -GTP levels of subjects were respectively measured upon initial collection of blood before alcohol administration and upon final collection of blood after alcohol administration. The results are given in Table 7 below. As to liver function values after drinking, the control group exhibited relatively high values as compared to the hangover cure-intake group.
- hangover symptoms refer to various aftereffects following intake of alcoholic beverages, such as headache, diarrhea, anorexia, nausea, vomiting and the like. Therefore, after administration of alcohol into subjects, hangover symptoms were compared therebetween. From questionnaire results, it was confirmed that the control group exhibited a relatively high frequency of symptoms as compared to the hangover cure-intake group, as evident by headache (hangover cure-intake group: 1, control group: 2), vomiting (hangover cure-intake group: 0, control group: 2), asthenia (hangover cure-intake group: 0, control group: 1), and sensitivity to stimuli (hangover cure-intake group: 0, control group: 1).
- blood pressure and pulse rate of subjects were respectively measured before alcohol administration and at time points of 0.5, 1, 2, 4, 6 and 15 hours after alcohol administration during the first test and second test. According to the results thus measured, abnormal responses were not observed in both the hangover cure-intake group and control group. Further, blood pressure began to decrease after alcohol administration, reached the lowest level at around 4 hours after alcohol intake, and thereafter gradually increased to recover to the normal state at 15 hours. Such a pattern of the blood pressure exhibited a tendency proportional to the blood alcohol concentration. In addition, similar to the raw unripe red pepper extract of Example 1, the substantially same clinical test results were also obtained for the raw ripe red pepper extract of Example 2.
- Example 7 Using the red pepper extract obtained in Example 7 as a sample, a clinical test for hangover-relieving effects thereof on humans was carried out. The test was performed by Dept. of Preventive Medicine Yonsei Univ. Wonju College of Medicine (Wonju, Korea).
- the hangover cure-intake group generally exhibited the blood alcohol concentration lower than that of a control (non-intake) group.
- the time to reach the highest level of the blood alcohol concentration after alcohol consumption was 2 hours after drinking for the hangover cure- intake group and 1 hour for the control group, respectively, thus representing that the hangover cure-intake group took a relatively longer time to reach the highest alcohol concentration.
- the alcohol concentration gradually decreased after 2 hours, and substantially no blood alcohol was detected in both groups after 15 hours.
- the blood alcohol concentration after alcohol consumption, which reached the highest blood level was 99.56 mg/dL (2 hours after drinking) for the hangover cure-intake group and 111.6 mg/dL (1 hour after drinking), respectively.
- the blood alcohol concentration of the hangover cure-intake group was lower than that of the control group, at all of the time points.
- Blood alcohol concentrations of a group to which the hangover cure of the present invention was administered and a control group, with respect to respective time points of blood collection after drinking (Unit: mg/dL)
- liver function values of subjects [251] Blood SGPT(ALT), SGOT(AST) and ⁇ -GTP levels of subjects were respectively measured upon initial collection of blood before alcohol administration and upon final collection of blood after alcohol administration. The results are given in Table 10 below. As to liver function values after drinking, the control group exhibited relatively high values as compared to the hangover cure-intake group.
- Liver function values of a group to which the hangover cure of the present invention was administered and a control group, before and after drinking (Unit:mg/dL)
- hangover symptoms refer to various aftereffects following intake of alcoholic beverages, such as headache, diarrhea, anorexia, nausea, vomiting and the like. Therefore, after administration of alcohol into subjects, hangover symptoms were compared therebetween. From questionnaire results, it was confirmed that the control group exhibited a relatively high frequency of symptoms as compared to the hangover cure-intake group, as evident by asthenia (hangover cure-intake group: 2, control group: 4), sensitivity to stimuli (hangover cure-intake group: 0, control group: 2), sticky sweat (hangover cure-intake group: 0, control group: 2), and memory blackout (hangover cure-intake group: 0, control group: 2).
- the final analysis was carried out for twenty subjects.
- the blood alcohol concentration of the hangover cure-intake group was lower than that of the control group, at all of the time points.
- the blood alcohol concentration of the hangover cure-intake group was low up to one hour after alcohol consumption. From comparison results of hangover symptoms after administration of alcohol into subjects, it was confirmed that the control group exhibited a higher frequency of symptoms including asthenia, sensitivity to stimuli, sticky sweat, and memory blackout, as compared to the group to which the hangover cure of the present invention was administered.
- the blood pressure and pulse rate of subjects were respectively measured before alcohol administration and at time points of 0.5, 1, 2, 4, 6 and 15 hours after alcohol administration during the first test and second test. According to the results thus measured, abnormal responses were not observed in both the hangover cure-intake group and control group. Further, the blood pressure began to decrease after alcohol administration, reached the lowest level at around 4 hours after alcohol intake, and thereafter gradually increased to recover to the normal state at 15 hours. Such a pattern of the blood pressure exhibited a tendency proportional to the blood alcohol concentration. In addition, similar to the raw unripe red pepper extract of Example 7, the substantially same clinical test results were also obtained for the raw ripe red pepper extract of Example 8.
- the red pepper extract obtained in Example 1 or 2, or Example 7 or 8 may be used directly as a beverage, or may be otherwise prepared into a beverage form via combination with other beverage components.
- 20 mL of the extract can be administered as a single dose or in two divided doses, before and/or after alcohol drinking.
- a beverage was prepared by adding 10% by weight of the raw unripe red pepper extract obtained in Example 1 to a common orange juice.
- a beverage was prepared by mixing 20% by weight of the raw unripe red pepper extract obtained in Example 1 and 80% by weight of water.
- a beverage was prepared by adding 15% by weight of the raw ripe red pepper extract obtained in Example 2 to a common apple juice.
- a beverage was prepared by mixing 12% by weight of the raw ripe red pepper extract obtained in Example 2 and 88% by weight of water.
- a beverage was prepared by adding 10% by weight of the raw unripe red pepper extract obtained in Example 7 to a common orange juice.
- a beverage was prepared by mixing 20% by weight of the raw unripe red pepper extract obtained in Example 7 and 80% by weight of water.
- a beverage was prepared by adding 15% by weight of the raw ripe red pepper extract obtained in Example 8 to a common apple juice.
- a beverage was prepared by mixing 12% by weight of the raw ripe red pepper extract obtained in Example 8 and 88% by weight of water.
Abstract
Provided is a hangover cure containing a raw red pepper extract and a health food containing the same. Specifically, provided is a hangover cure comprising a raw red pepper extract as an active ingredient, and a health food having hangover-relieving effects via inclusion of the hangover cure. The hangover cure has alcohol hangover-relieving effects such as reduction of an alcohol concentration, and can be easily taken via addition thereof to alcoholic beverages, or can be conveniently taken before and/or after alcohol drinking.
Description
Description
HANGOVER CURING AGENT CONTAINING A RAW UNRIPE RED PEPPER EXTRACT AND HEALTH SUPPORTING FOODS
CONTAINING THE SAME
Technical Field
[1] The present invention relates to a hangover cure containing a raw red pepper extract and a health food containing the same. More specifically, the present invention relates to a hangover cure containing a raw red pepper extract, which is effective for prevention and relief of alcohol-induced hangovers, and which can be easily taken via addition thereof to alcoholic beverages, or can be conveniently taken before and/or after alcohol drinking; and a health food containing the same.
[2]
Background Art
[3] Many people show much interest in drugs that can cure or alleviate alcohol hangovers, resulting from heavy drinking and frequent imbibing due to the country's heavy and unique drinking culture. Ethanol may exert toxicity by itself as well as may be converted into harmful substances in the course of metabolic processes in the body. Such metabolites serve as substances detrimental to the brain and the digestive organs including the liver, thereby leading to hangovers following intake of alcohols. Hangovers are accompanied by headaches or upset stomachs after ethanol intake, and a great deal of research is being actively undertaken for finding drugs that are capable of reducing or relieving hangover symptoms. Even though a variety of drugs for this purpose have already been introduced in the related art, there is yet few known drugs having outstanding therapeutic effects on alcohol hangovers (Lieber C. S., Acta Scand. supple., 703).
[4] Alcohols, which are not stored in tissues unlike other foodstuffs, are oxidized into acetaldehyde by catalytic action of alcohol dehydrogenase (ADH), largely in the liver, and when metabolism progresses further, the resulting acetaldehyde is broken down into acetic acid and H by catalytic action of aldehyde dehydrogenase (ALDH) (Jae-Youl Cho, et al., Korean Journal of Food Science & Technology, 29 (1), 167-172 (1997)). 90% of the thus-formed acetic acid is directly converted into CO and H O, and the remaining 10% thereof is completely degraded via TCA cycle (Jae-Youl Cho, et al.; Lieber CS. and Leo M.A., In Progress in liver diseases, Popper, H. and Schaffner, F. (Ed), Grune and Stration, New York, p. 253 (1986); and Linder M.C.). However, when ingesting excessive amounts of alcohols, a microsomal ethanol oxidizing system (MEOS), in addition to ADH, also takes part in oxidization of
ethanol into aldehyde which is then finally converted into CO and H O (Linder M.C. supra). As to a mechanism whereby chronic ethanol intake causes hyperlipidemia and fatty liver, there is a theory in which metabolism of ethanol by the action of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) leads to an increase in the NADH/NAD+ ratio in the liver and cells, and such changes in turn lead to an increase in oxidation of fatty acids and activity of TCA cycle in hepatocytes, thereby causing fatty liver (Murray R.K. et al., Harper's Biochemistry, Appleton and Lange, Connecticut, USA. 3rd ed, p260 (1993)).
[5] In addition, it is said that acetaldehyde, known as a primary cause of hangovers, exhibits high affinity for sulfur-containing materials including cysteine and glutathione, in liver microsomes, and induces changes in the lipid composition of plasma membranes, thereby causing liver damage such as fatty liver and liver necrosis (Kaufman N. et al., AM. A. Arch. Path 70, 331 (I960)).
[6] Depending upon intake amounts, alcohols exhibit various effects on the body. For example, intake of large amounts of alcohols within a short period of time results in accumulation of aldehyde in conjunction with the accompanying symptoms such as vomiting, headache, lowering of blood pressure, tachycardia and shock, and particularly interferes with lipid oxidation in the liver or drug metabolism in the endoplasmic reticulum. Chronic ingestion of alcohols induces adaptability which results in increased metabolism of alcohols and drugs and accelerates production of lipoproteins, thereby leading to damage of hepatocytes (Rosser B. G. and Gores GJ., Gastroenterology, 108, 252 (1995)). These potentially harmful phenomena may arise from destruction of hepatocytes, inhibition of chemical equilibrium of hepatocytes, metabolic abnormalities and mitochondrial dysfunctions, due to peroxidation which takes place upon production of acetaldehyde and excessive amounts of NADH formed by catalysis of MEOS (Bunsel R.G. and Lehmann A.G., Behav. Brain Res. 1, 351 (1980)). Such adverse reactions and harmful substances cause injury to hepatocytes, resulting in accumulation of fatigue substances such as lactic acid, decrease the activity of ALDH, inhibit activation of vitamins to thereby decrease levels of blood vitamins and also inhibit myocardial protein synthesis. Further, increased amounts of hydrogen molecules participate directly or indirectly in synthesis of fatty acids, thereby formation of fats which ultimately leads to a pathological phenomenon, called fatty liver (Lieber CS. and Leo M.A.; Tkabe M. and Itokawa Y., J. Nutr. Sci. Viaminol., 29, 509 (1983)).
[7] Meanwhile, recently, a great deal of research and experiments have been actively undertaken for finding various kinds of feasible candidate substances that are capable of reducing or relieving toxicity of ethanol or suppressing expression of ethanol toxicity. As a consequence, a variety of health foods for this purpose have been
developed or are being developed which contain components extracted from natural foodstuffs or herbal medicine materials, or contain artificial materials.
[8] However, even though many kinds of drinks, which were prepared using herbal medicine materials or artificial materials, have been developed and are commercially available in order to solve the problems associated with adverse effects resulting from alcohol hangovers or alcohol toxicity, there is yet few known preparations having satisfactory effects.
[9]
Disclosure of Invention Technical Problem
[10] Therefore, the present invention has been made in view of the above problems, and it is an object of the present invention to provide a hangover cure which is effective for prevention and relief of alcohol hangovers, and which can be easily taken via addition thereof to alcoholic beverages, or can be conveniently taken before and/or after alcohol drinking.
[11] It is another object of the present invention to provide a health food containing the above-mentioned hangover cure.
[12]
Technical Solution
[13] As a result of a variety of extensive and intensive studies and experiments to develop a hangover cure having superior effects for relief of alcohol-induced hangovers, utilizing various species of plants, the inventors of the present invention have surprisingly discovered, as will be described hereinafter, the fact that a raw red pepper extract reduces an alcohol concentration and is effective to alleviate hangovers. The present invention has been completed based on these findings.
[14] In accordance with an aspect of the present invention, the above and other objects can be accomplished by the provision of a hangover cure comprising a raw red pepper extract as an active ingredient.
[15] In accordance with another aspect of the present invention, there is provided a health food having hangover-relieving effects by inclusion of the above-mentioned hangover cure.
Advantageous Effects
[16] The hangover cure according to the present invention has alcohol hangover- relieving effects such as reduction of an alcohol concentration, and can be easily taken via addition thereof to alcoholic beverages, or can be conveniently taken before and/or after alcohol drinking.
[17]
Brief Description of the Drawings
[18] The above and other objects, features and other advantages of the present invention will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
[19] FIG. 1 is a graph showing the analysis results of GS-Mass Spectrometry for addition of sample E at a 2% concentration, as a representative example according to the present invention;
[20] FIG. 2 is a graph showing a calibration curve for experimental data obtained from
GS-Mass Spectrometry, and data prior to conversion thereof into % values;
[21] FIG. 3 is a graph showing comparison results of blood alcohol concentrations with a varying blood-collecting period of time, after alcohol was drunk by a group which had ingested a hangover cure according to the present invention and a control group, respectively; and
[22] FIG. 4 is a graph showing comparison results of blood alcohol concentrations with a varying blood-collecting period of time, after alcohol was drunk by a group which had ingested a hangover cure extracted according to another method of the present invention and a control group, respectively.
[23]
Best Mode for Carrying Out the Invention
[24] Hereinafter, the present invention will be described in more detail.
[25] Pungent taste in red peppers is due to capsaicin
(8-methyl-N-vanillyl-6-nonenamide) which is known to facilitate secretion of gastric juices, thereby resulting in improvement of appetite, and have blood-circulation promoting effects. In addition, red peppers are known to exhibit muco-kinetic action which dilutes the mucus and allows for easy excretion of phlegm, and exert analgesic action via temporal sensory neuron blocking effects. However, excessive intake of red peppers irritates the gastrointestines and thereby results in gastric mucosal lesions, diarrhea and hepatic insufficiency.
[26] Even though the mechanisms of how a raw red pepper extract used in the present invention acts to prevent and relieve alcohol hangovers have not yet been fully elucidated, the present inventors have unexpectedly confirmed through various and intensive experiments that the raw red pepper extract reduces a concentration of alcohols and is also effective to relieve alcohol-induced hangovers upon application thereof to the body.
[27] The hangover cure of the present invention contains a raw red pepper (including both unripe and ripe red peppers) extract as an active ingredient. Herein, a content of the raw red pepper extract is not particularly limited and the hangover cure may
contain, for example 2 to 100% by weight of the raw red pepper extract, based on the total weight of the hangover cure. That is, the raw red pepper extract per se may be used as the hangover cure or otherwise may be used as the hangover cure in combination with other ingredients such as water, beverage ingredients and the like. Preferably, in the hangover cure of the present invention, the remaining ingredients other than the raw red pepper extract may be composed of water.
[28] Further, in addition to the raw red pepper extract, the hangover cure of the present invention may contain pyroligneous liquor. The pyroligneous liquor serves to prevent alteration of the hangover cure of the present invention. Although there is no particular limit to an amount of the pyroligneous liquor added, it is preferred to add the pyroligneous liquor in an amount of 0.5 to 5% by weight, based on the total weight of the hangover cure. Preferably, the pyroligneous liquor that can be used in the present invention may be composed of 2 to 4% by weight of acetic acid, 0.05 to 0.15% by weight of formic acid, 0.05 to 0.15% by weight of propionic acid, 1 to 3% by weight of mugwort components, 0.01 to 1% by weight of sodium acetate (or zinc sulfate), and the balance of purified water.
[29] Further, the hangover cure of the present invention may further contain a garlic extract. The garlic extract is added as an auxiliary substance to assist in relief of the hangover. Therefore, use of the garlic extract in conjunction with the raw red pepper extract results in synergistic hangover-relieving effects. An added amount of the garlic extract may be preferably in a range of 0.5 to 10% by weight without being limited thereto, based on the total weight of the hangover cure.
[30] The hangover cure of the present invention may be provided in the form of capsules, tablets or health drinks. Alternatively, the hangover cure may also be in the form of health foods containing the above hangover cure as an active ingredient, for example including various forms such as tea, jelly, sap, juice, extract, beverage and other favorite foods. Here, the content of the hangover cure may be, without limitation, in the range of 0.1 to 20% by weight.
[31] In addition to the raw unripe red pepper extract, the hangover cure or beverage of the present invention may optionally contain herbal medicine components such as ginseng ingredients, or various vitamins or minerals, citric acid, sodium citrate, malic acid, lecithin, lactic acid, amino acid, sugar, honey, fructose, natural flavors, natural pigments and the like, as food additives known in the art.
[32] The raw red pepper extract, which is utilized in the hangover cure of the present invention, may be obtained by squeezing the juice of red peppers, followed by distillation. Preferably, the red pepper extract may be prepared according to the following extraction process. That is, the process includes the steps of:
[33] 1. Washing raw unripe or ripe red peppers with water and dehydrating the washed
materials to remove moisture;
[34] 2. Squeezing the juice of red peppers in a press fashion; and
[35] 3. Heating the squeezed juice to 50 to 11O0C, passing the resulting steam through a cooling device to collect the condensed liquid, and subjecting the distilled and condensed liquid to filtration under reduced pressure; or
[36] 1. Washing raw unripe or ripe red peppers with water and dehydrating the washed materials to remove moisture;
[37] 2. Squeezing the juice of red peppers in a press fashion;
[38] 3. Heating the squeezed juice with stirring at a temperature of 90 to 11O0C until no bubbles are formed;
[39] 4. Cooling the heated juice at room temperature for 3 to 4 hours, thereby separating the juice into a top layer of a liquid phase and a bottom layer of aggregates, and collecting the liquid layer therefrom;
[40] 5. Heating the liquid layer fraction to 70 to 1150C and passing the resulting steam through a cooling device, followed by collecting the condensed liquid; and
[41] 6. Subjecting the distilled and condensed liquid to filtration under reduced pressure.
[42]
[43] Hereinafter, the corresponding steps will be described in more detail, respectively.
[44] Red peppers begin to bear fruits from early summer. Such green fruits are called unripe red peppers. When red peppers are allowed to grow without collection of fruits, the green fruits turn into red colored fruits, called ripe red peppers, around the middle of August. The time of changing from unripe green color to ripe red color is not constant while showing variations depending upon cultivation techniques and regions. Generally, unripe red pepper fruits may be harvested about 15 days after blooming, and 50 days later, ripe red fruits may be harvested. According to the present invention, as will be illustrated hereinafter, the unripe and ripe red peppers may be used separately or in combination thereof because both of them exhibit almost the same effects on alleviation of alcohol hangovers.
[45] In connection with preparation of the raw red pepper extract as above, it is preferred to employ only purified water without use of a detergent, upon washing raw materials. Squeezing is carried out by a screw press-type method involving placing the red pepper raw materials in a screw press and pressing to squeeze them.
[46] In the above first method, the squeezed juice is heated to a temperature range of 50 to 11O0C and the resulting steam is passed through a cooling device, followed by collecting the condensed liquid to obtain a distillate. More preferably, the squeezed juice is heated to 80 to 9O0C. In this connection, distillation of the squeezed juice in the above temperature range leads to co-existence of active ingredients (such as as- paraginie, aspartic acid and the like) of red peppers in the resulting trace distillate by
azeotropy.
[47] In the above second method, the squeezed juice is preferably heated at a temperature of 90 to 11O0C with stirring until no formation of bubbles occurs. A heating period of time usually takes about 30 min. Heating of the squeezed juice in the above temperature range enables better elution of active ingredients contained in red peppers. In addition, by heating the squeezed juice with stirring until no formation of bubbles occurs, it is possible to ensure aggregation and sterilization of various organic nutritive substances such as starches, celluloses and proteins. More preferably, the heating step is conducted at a temperature of 100 to 11O0C.
[48] After heating the squeezed juice, the heated juice is cooled at room temperature
(about 15 to 250C) for 3 to 4 hours and is allowed to stand at that temperature, thereby resulting in separation of two layers. That is, a liquid phase is formed as a top layer, while aggregates are formed as a bottom layer. The liquid layer corresponding to the top layer fraction is collected from two separated layers, and is then condensed by distillation.
[49] As described hereinbefore, the liquid layer is heated to a temperature range of 70 to
1150C and the resulting steam is passed through a cooling device, followed by collecting the condensed liquid to obtain a distillate. In this connection, distillation of the liquid layer in the above temperature range leads to co-existence of active ingredients (such as capsaicin) of red peppers in the resulting distillate by azeotropy. More preferably, the liquid layer fraction is heated to 90 to 1150C.
[50] Upon subjecting the distillation-condensed liquid obtained by the above-mentioned two methods to filtration under reduced pressure, there is no particular limit to a filter used for this purpose. Since it is possible to obtain a more transparent liquid phase, use of a fiber filter having a pore size of less than 1 D is preferred.
[51] After inspection of the thus-obtained filtrate under standards specified by Food
Sanitation Law, it is preferred to select only the liquid phase of the raw materials which meet the specified standard requirements. For example, characteristics and properties of materials of interest should meet the following requirements: unique color and gloss while being free of off- taste and off-flavor, less than 0.3 mg/kg of lead (Pb), less than 0.1 mg/kg of cadmium (Cd) and less than 150 mg/kg of tin (Sn), less than 100 bacteria/mL, and having no Coliform group bacteria.
[52] The method for preparing the raw red pepper extract may further include filling the filtrate in a brown glass bottle container and sterilizing the contents at a temperature of 80 to 9O0C for 10 to 20 min. Herein, the reason why the brown glass bottle is used upon filling thereof is to prevent oxidation of the extract due to direct or indirect exposure thereof to UV light. Therefore, among brown glass bottles, it is preferred to use those to which UV-blocking pigments were incorporated. Where sterilization of
the contents of the bottle is performed outside the above-mentioned conditions, it is difficult to sufficiently achieve desired sterilization effects or it may disadvantageously result in undesirable effects on characteristics of the products.
[53] The extract according to the present invention may be used as a beverage as it is, or may be otherwise prepared into a beverage formulation via combination with other beverage components. For example, upon preparing the beverage, 0.1 to 20% by weight of the extract is combined to be incorporated into the beverage. Preferably, the beverage may be composed of 0.1 to 20% by weight of the extract of the present invention and the balance of water.
[54] The hangover cure of the present invention can be drunk via addition thereof to alcohols, upon intake of alcoholic liquors, or can be directly taken before and/or after alcohol drinking. When it is desired to take it before and/or after alcohol intake, a dose of the hangover cure may vary depending upon intake amounts of alcohols, body weight, sex and liver functions of subjects. For adults weighing 60 kg, it is preferred to administer the hangover cure at a dose of about 1 to 15 g for each time and preferably 5 to 10 g. If the dose of the hangover cure is excessively low, i.e., below 1 g, it is impossible to achieve hangover-relieving effects as desired. In contrast, if the dose of the hangover cure exceeds 1O g, this may result in gastric irritation. When the hangover cure of the present invention is administered in admixture with an alcoholic beverage, it is preferred to add the hangover cure in a ratio of 0.5 to 5 vol% to the alcoholic beverage.
[55]
Mode for the Invention
[56] EXAMPLES
[57]
[58] Now, the present invention will be described in more detail with reference to the following examples. These examples are provided only for illustrating the present invention and should not be construed as limiting the scope and spirit of the present invention.
[59]
[60] Example 1 : Preparation of raw unripe red pepper extract
[61] Domestic raw unripe red peppers (Capsicum annuum L), matured about 20 days after blooming, were purchased, and rotten and worm-eaten red peppers were picked out, followed by removal of stems thereof. The selected red peppers were completely washed with purified water without using a detergent, thereby removing foreign materials such as contaminants, soil and dust. Next, moisture was removed from the washed materials which were then continuously introduced into a screw press squeezer
and were squeezed to obtain red pepper juice. The thus-squeezed juice was heated with stirring at a temperature of 1000C until no formation of bubbles was observed (it took 30 min). The heated red pepper liquid was allowed to stand at room temperature (about 2O0C) for 3 hours, thereby separating it into a top layer (a liquid phase) and a bottom layer (aggregates).
[62] The top layer (a liquid phase) was collected from the separated two layers, heated to 11O0C using a vacuum extractor (COSMOS 660, KyungSeo Machine Co., Inchon, Korea), while passing the evolving steam through a cooling tower, followed by collecting the condensed transparent liquid.
[63] Thereafter, the condensed transparent distillate liquid was subjected to filtration under reduced pressure, using a fiber filter having a pore size of 1 D. After inspection of the thus-obtained filtrate under standards specified by Food Sanitation Law, only the liquid phase of the raw materials which has satisfied the specified standard requirements was selected. Predetermined amounts of the liquid phase suitable for specified standard requirements were respectively filled in containers, followed by packaging. Packaged containers were sterilized at 8O0C for 10 min. The sterilized containers were labeled, indicated with the date of manufacture and wrapped in standard packaging boxes, thereby finishing manufacture of products. Products thus produced were colorless red pepper stock solutions and their characteristics were free of off-taste and off- flavor. The results of quality inspection test for products are given in Table 1 below.
[64] [65] Table 1
[66]
[67] In addition, general tests for bacteria and E.coli on the above products were performed by KOREA RED GINSENG Co., Ltd., and the results showed that bacteria were not detected in products and the Coliform group was negative.
[68]
[69] Example 2: Preparation of raw ripe red pepper extract
[70] Red pepper extracts were prepared in the same manner as in Example 1, except that raw ripe red peppers, matured about 50 days after blooming, were used as raw materials, instead of domestic raw unripe red peppers in Example 1.
[71] After inspection of the thus-obtained filtrate of the red pepper extract under standards specified by Food Sanitation Law, as described in Example 1, only the liquid phase of the raw materials which has satisfied the specified standard requirements was selected. Predetermined amounts of the liquid phase were respectively filled in containers, followed by packaging. Packaged containers were sterilized, labeled, indicated with the date of manufacture and wrapped in standard packaging boxes, thereby finishing manufacture of the products. Similar to the raw unripe red pepper products, the products thus produced were colorless red pepper stock solutions and their characteristics were free of off-taste and off- flavor. The results of quality inspection test for products are given in Table 1 above.
[72]
[73] Example 3: Preparation of raw unripe red pepper extract and pyroligneous liquor mixture
[74] Based on the total weight of the extract, 2% by weight of purified pyroligneous liquor was added to the raw unripe red pepper extract obtained in Example 1, thereby preparing a hangover cure.
[75] The pyroligneous liquor used herein was prepared according to a method disclosed in Korean Patent Application No. 2005-0098620, assigned to the present applicant. More specifically, the procedure for preparing the pyroligneous liquor will be described in more detail as follows. 600 g of crude pyroligneous liquor was introduced into a round bottom flask to which 2 g of 80% phosphoric acid was then added. Thereafter, the flask was equipped with a cooling condenser, and 24 g of 30% aqueous hydrogen peroxide was gradually added to the crude pyroligneous liquor. The resulting mixture was reacted for 8 hours by heating it to 7O0C with stirring at 110 rpm. Then, the reactants were allowed to stand at room temperature for 40 hours, and the resulting aggregates were filtered and distilled by heating in a distiller at a temperature of 90 to 12O0C for 4 hours, thereby obtaining 41O g of purified pyroligneous liquor (yield: ca. 68%). The thus-obtained pyroligneous liquor was composed of 2 to 4% by weight of acetic acid, 0.05 to 0.15% by weight of formic acid, 0.05 to 0.15% by weight of propionic acid, 1 to 3% by weight of mugwort components, 0.01 to 1% by weight of
sodium acetate and the balance of purified water.
[76]
[77] Example 4: Preparation of raw ripe red pepper extract and pyroligneous liquor mixture
[78] A hangover cure was prepared in the same manner as in Example 3, except that the raw ripe red pepper extract obtained in Example 2 was used, and 3% by weight of purified pyroligneous liquor was added based on the total weight of the extract.
[79]
[80] Example 5: Preparation of raw unripe red pepper extract and garlic extract mixture
[81] Based on the total weight of the extract, 5% by weight of a garlic extract was added to the raw unripe red pepper extract obtained in Example 1, thereby preparing a hangover cure. The garlic extract was prepared in the same manner as in Example 1, except that garlic was used as a raw material.
[82]
[83] Example 6: Preparation of raw ripe red pepper extract and garlic extract mixture
[84] A hangover cure was prepared in the same manner as in Example 5, except that the raw unripe red pepper extract obtained in Example 2 was used, and 8% by weight of a garlic extract was added based on the total weight of the extract.
[85]
[86] Example 7: Preparation of raw unripe red pepper extract
[87] Domestic raw unripe red peppers (Capsicum annuum L), matured about 20 days after blooming, were purchased, and rotten and worm-eaten red peppers were picked out, followed by removal of stems thereof. The selected red peppers were completely washed with purified water without using a detergent, thereby removing foreign materials such as contaminants, soil and dust. Next, moisture was removed from the washed materials which were then continuously introduced into a screw press squeezer and were squeezed to obtain a red pepper juice.
[88] The squeezed red pepper juice was heated to 9O0C using a vacuum extractor
(COSMOS 660, KyungSeo Machine Co., Inchon, Korea), while passing the evolving steam through a cooling tower, followed by collecting the condensed transparent liquid. Thereafter, the condensed transparent distillate liquid was subjected to filtration under reduced pressure, using a fiber filter having a pore size of 1 D.
[89] After inspection of the thus-obtained filtrate under standards specified by Food
Sanitation Law, only the liquid phase of the raw materials which has satisfied the specified standard requirements was selected. Predetermined amounts of the liquid phase suitable for specified standard requirements were respectively filled in containers, followed by packaging. Packaged containers were sterilized at 8O0C for 10 min. The sterilized containers were labeled, indicated with the date of manufacture and
wrapped in standard packaging boxes, thereby finishing manufacture of the products. Products thus produced were colorless red pepper stock solutions and their characteristics were free of off-taste and off- flavor. The results of quality inspection test for products are given in Table 2 below.
[90] [91] Table 2
[92] [93] In addition, general tests for bacteria and E.coli on the above products were performed by KOREA RED GINSENG Co., Ltd., and the results showed that bacteria were not detected in products and the Coliform group was negative.
[94] [95] Example 8: Preparation of raw ripe red pepper extract [96] Red pepper extracts were prepared in the same manner as in Example 7, except that raw ripe red peppers, matured about 50 days after blooming, were used as raw materials, instead of domestic raw unripe red peppers in Example 7.
[97] After inspection of the thus-obtained filtrate of the red pepper extract under standards specified by Food Sanitation Law, as described in Example 7, only the liquid phase of the raw materials which has satisfied the specified standard requirements was selected. Predetermined amounts of the liquid phase were respectively filled in containers, followed by packaging. Packaged containers were sterilized, labeled, indicated with the date of manufacture and wrapped in standard packaging boxes, thereby finishing manufacture of the products. Similar to the raw unripe red pepper products, the products thus produced were colorless red pepper stock solutions and their characteristics were free of off-taste and off- flavor. The results of quality
inspection test for products are given in Table 2 above.
[98]
[99] Example 9: Preparation of raw unripe red pepper extract and pyroligneous liquor mixture
[100] Based on the total weight of the extract, 2% by weight of purified pyroligneous liquor was added to the raw unripe red pepper extract obtained in Example 7, thereby preparing a hangover cure.
[101] The pyroligneous liquor used herein was prepared according to a method disclosed in Korean Patent Application No. 2005-0098620, assigned to the present applicant. More specifically, the procedure for preparing the pyroligneous liquor will be described in more detail as follows. 600 g of crude pyroligneous liquor was introduced into a round bottom flask to which 2 g of 80% phosphoric acid was then added. Thereafter, the flask was equipped with a cooling condenser, and 24 g of 30% aqueous hydrogen peroxide was gradually added to the crude pyroligneous liquor. The resulting mixture was reacted for 8 hours by heating it to 7O0C with stirring at 110 rpm. Then, the reactants were allowed to stand at room temperature for 40 hours, and the resulting aggregates were filtered and distilled by heating in a distiller at a temperature of 90 to 12O0C for 4 hours, thereby obtaining 41O g of purified pyroligneous liquor (yield: ca. 68%). The thus-obtained pyroligneous liquor composed of 2 to 4% by weight of acetic acid, 0.05 to 0.15% by weight of formic acid, 0.05 to 0.15% by weight of propionic acid, 1 to 3% by weight of mugwort components, 0.01 to 1% by weight of sodium acetate and the balance of purified water.
[102]
[103] Example 10: Preparation of raw ripe red pepper extract and pyroligneous liquor mixture
[104] A hangover cure was prepared in the same manner as in Example 9, except that the raw ripe red pepper extract obtained in Example 8 was used, and 3% by weight of purified pyroligneous liquor was added based on the total weight of the extract.
[105]
[106] Example 11 : Preparation of raw unripe red pepper extract and garlic extract mixture
[107] Based on the total weight of the extract, 5% by weight of a garlic extract was added to the raw unripe red pepper extract obtained in Example 7, thereby preparing a hangover cure. The garlic extract was prepared in the same manner as in Example 7, except that garlic was used as a raw material.
[108]
[109] Example 12: Preparation of raw ripe red pepper extract and garlic extract mixture
[110] A hangover cure was prepared in the same manner as in Example 11, except that
the raw ripe red pepper extract obtained in Example 8 was used, and 8% by weight of a garlic extract was added based on the total weight of the extract.
[111] [112] Example 13: Effects of red pepper extract on alcohol concentration [113] Using the red pepper extract obtained in Example 1 as a sample, a test for alcohol concentration-reducing effects thereof was repeatedly carried out four times: Sample A, once; Sample B, twice; Sample D, thrice; and Sample E, four times. In addition, using the raw ripe red pepper extract obtained in Example 2 as a sample, a test for alcohol concentration-reducing effects of the extract (Sample F) was carried out. The same test was also conducted for the sample to which the pyroligneous liquor obtained in Example 3 was added (Sample C). The tests were performed by the Institute of Environment of Kyunggi University (Seoul, Korea). Test methods are as follows.
[114] Each sample was added in 2% and 5% concentrations to 50 mL of Soju, traditional Korean distilled liquor ('Cham-ee-seul', Jinro, Korea) contained in flasks which were then stirred for 3 min and sealed with stoppers. Reactants were collected with syringes, at intervals of 30 min, 1 hour and 2 hours, respectively and alcohol concentrations were analyzed using a Gas Chromatography-Mass Spectrometer (GC-MS). In order to reduce experimental error to the maximum extent possible, syringes were dried in an oven at 5O0C for 30 sec each time prior to use. As a control, a sample in which nothing was added to Soju was used. The results thus obtained are given in Table 3 below. In addition, FIG. 1 is a graph showing the analysis results of GS-Mass Spectrometry for addition of sample E at a 2% concentration, as a representative example according to the present invention, and FIG. 2 is a graph showing a calibration curve for experimental data obtained from GS-Mass Spectrometry, in conjunction with data prior to conversion thereof into % values.
[115] [116] Table 3 Alcohol concentration-reducing effects of red pepper extracts
[117] [118] As can be seen from Table 3 above, it was confirmed that an alcohol concentration was significantly decreased thus showing a concentration of 13.14 to 16.97%, 2 hours after the hangover cure, based on the red pepper extract according to the present invention as a main component, was added in an amount of 2 to 5% by weight to Soju.
[119] [120] Example 14: Effects of red pepper extract on alcohol concentration [121] Using the raw unripe red pepper extract obtained in Example 7 as a sample, a test for alcohol concentration-reducing effects thereof was repeatedly carried out three times: Sample G, once; Sample H, twice; and Sample J, thrice. In addition, using the raw ripe red pepper extract obtained in Example 8 as a sample, a test for alcohol concentration-reducing effects of the extract (Sample K) was carried out. The same test was also conducted for the sample to which the pyroligneous liquor obtained in Example 9 was added (Sample I). The tests were performed by the Institute of Environment of Kyunggi University (Seoul, Korea). Test methods are as follows.
[122] Each sample was added in a 5% concentration to 50 mL of Soju, traditional Korean distilled liquor ('Cham-ee-seul', Jinro, Korea) contained in flasks which were then stirred for 3 min and sealed with stoppers. Reactants were collected with syringes, at intervals of 30 min, 1 hour and 2 hours, respectively and alcohol concentrations were analyzed using a Gas Chromatography-Mass Spectrometer (GC-MS). In order to reduce experimental error to the maximum extent possible, syringes were dried in an oven at 5O0C for 30 sec each time prior to use. As a control, a sample in which nothing was added to Soju was used. The results thus obtained are given in Table 4 below.
[123] [124] Table 4 Alcohol concentration-reducing effects of red pepper extracts
[125] [126] As can be seen from Table 4 above, it was confirmed that an alcohol concentration
was significantly decreased thus showing a concentration of 14.5 to 16.0%, 2 hours after the hangover cure, based on the raw unripe and ripe red pepper extracts according to the present invention as a main component, was added in an amount of 5% by weight to Soju.
[127]
[128] Example 15: Clinical Tests
[129] Using the red pepper extract obtained in Example 1 as a sample, a clinical test for hangover-relieving effects thereof on humans was carried out. The test was performed by Dept. of Preventive Medicine Yonsei Univ. Wonju College of Medicine (Wonju, Korea).
[130] 10 healthy adults, aged from 20 to 40 and suitable for the criteria of selection, were asked to prepare prior consents and answer questionnaires, and the test for hangover- relief functional effects of the red pepper extract was performed. Saline-locked angio- catheters were inserted into brachial veins of subjects, prior to administration of alcohols, and blood was collected eight times, i.e., at the time points of 0, 0.25, 0.5, 1, 2, 4, 6 and 15 hr, respectively after intake of alcohol. The thus-collected blood was immediately placed in vacuum blood collection tubes and centrifuged at 3,000 rpm for 15 min to thereby separate sera. 1 mL of the separated sera was aliquoted into each airtight e-tube which was then freeze-stored at -2O0C until analysis and transferred to an analysis room using dry ice and a transfer vessel, and final alcohol concentrations in the blood were measured. For evaluation of vital signs, blood pressure, pulse rate and body temperature of subjects were respectively measured before alcohol administration and at time points of 0.5, 1, 2, 4, 6 and 15 hours after alcohol administration during the first test and second test. In addition, the subjects were examined as to whether they exhibited abnormal responses due to alcohol administration.
[131]
[132] <Test ranges>
[133] The present inventors have tried to make an examination to find out what effects does the hangover cure according to the present invention have on relief of alcohol hangovers, as compared to a control. Alcohol hangovers refer to the aftereffects following the consumption of large amounts of alcoholic beverages, which are accompanied by headaches, diarrhea, anorexia, nausea, vomiting and the like. Alcohol hangovers are caused by various factors including dehydration, toxicity of alcohols and metabolites thereof, and malabsorption. For objective evaluation of subjective symptoms in this test, determination of blood alcohol concentrations and other clinical examinations were conducted.
[134]
[136] [137] <Test items and test results> [138] A. Performance contents and Methods [139] 1) Subjects [140] 10 healthy adults (age of 20 to 40) were selected according to the following criteria of selection. 3 people out of ten subjects, who corresponded to the exclusion criteria (such as vomiting and stopping drinking), were excluded from the final analysis.
[141] a) Selection of subjects [142] Subjects were selected based on the result tables of prior health examination. [143] [144] b) Selection criteria of subjects
[145] - Age: 20 to 40 years old
[146] - Body weight: 60 to 75 kg, BMI(Body Mass Index): 18.5 - 23.0 kg/D
[147] - Sex: Male
[148] - People determined to have no congenital or chronic diseases and no clinical symptoms of diseases or no predispositions to pathogenesis via medical examination for internal diseases [149] - People with results of clinico-pathological examination and vital signs falling within a normal range
[150] - People who have voluntarily signed a written consent
[151]
[152] c) Exclusion criteria of Subjects
[153] - People who took drugs for induction and inhibition of drug-metabolizing enzymes such as barbitals, within one month before initiation of tests [154] - People who ingested alcoholic beverages in excessive amounts which might adversely affect the test, within 7 days before initiation of tests [155] - People who were taking anti-gastric ulcer drugs upon subjecting to the test, or received gastric ulcer treatments within last 6 months [156] - People with a medical or surgical history of pancreatitis, gout, gastrointestinal tract surgery
[157] - Hepatitis B or C patients or carriers
[158] - People who are considered as improper subjects by determination of the physician in charge, such as people who are taking drugs that are believed to affect alcohol metabolism
[159] - People who take drugs having the risk of occult bleeding such as aspirin
[160] - People who were determined as improper subjects by the physician in charge, among people who experienced severe symptoms of heart diseases or severe adverse side effects after alcohol intake
[161] - People with a medical history of psychiatric diseases in the past
[162]
[163] d) Disqualification criteria of Subjects
[164] - When subjects do not follow usage and dosage of specified drugs
[165] - When physicians have made a conclusion that the test cannot be performed any longer due to adverse side effects occurred during a test period or patients have rejected the test [166] - When surgical operation or hospital treatment is necessary due to disasters such as accidents or pathogenesis of other diseases [167] - When physicians have made a conclusion that the test cannot be performed any longer due to other reasons and factors
[168] - When subjects vomit after alcohol intake during a test period
[169]
[170] 2) Administration method and dose
[171] a) Administration method
[172] - All the members of subjects were gathered 12 hours prior to initiation of tests, and were fed with a standard diet (low-fat diet) for breakfast, lunch and evening meals. [173] - Subjects were orally administered a test material or a placebo, 2 hours after evening meals. [174] - 30 min after administration of the test material or placebo (a hangover cure beverage ingested 30 min prior to alcohol intake), alcohol was ingested within 30 min. [175] - Subjects were permitted to take minimal amounts of some eatables as a side dish for alcohol drinking (for example, about 20 chips of "Saewookkang" a kind of Korean shrimp snack cracker).
[176] - Subjects fasted for 4 hours after alcohol intake.
[177] - Subjects were allowed to drink water from 2 hours after alcohol intake
[178]
[179] b) Administration dose
[180] - Test material and placebo: single dosage forms of test products (20 mL)
[181] - Alcohol: 415 mL of Soju containing 90 g of alcohol ('Cham-ee-seul', Jinro, Korea)
[182]
[183] 3) Observation items and method
[184] a) Preparation of prior consents for selection of subjects
[185] Subjects were allowed to voluntarily sign written consents
[186]
[187] * Clinical items including population and social factors
[188] - Name, age, sex, current body weight and height
[189] * Various lifestyle habits and behavior patterns related to alcohol drinking
[190] - Quantity of drinking, drinking habits, food habits and food preference, smoking or nonsmoking and smoking history, exercise habits, drinking status of the family, physical symptoms and severity thereof following drinking, behavior characteristics related to alcohol drinking and the like. [191]
[192] b) Examination method
[193] 1) Determination of blood alcohol concentration
[ 194] - Blood collection
[195] Saline-locked angio-catheters were inserted into left brachial veins of subjects, prior to administration of alcohol, and blank blood was collected and 1 mL of saline was injected again into the catheters, thereby preventing blood clotting.
[196] - After intake of alcohol, blood was collected eight times, i.e., at the time points of
0, 0.25, 0.5, 1, 2, 4, 6 and 15 hr, respectively.
[197] - Upon collecting blood, about 1 mL of blood was taken out, about 6 mL of blood was collected and 1 mL of saline was injected again into the catheters, thereby preventing blood clotting.
[198] - The thus-collected blood was immediately placed in a vacuum blood collection tube (gel tubes) and centrifuged (3,000 rpm, 15 min) to separate sera. 1 mL of the separated sera was aliquoted into each airtight e-tube which was then freeze-stored at - 2O0C until analysis.
[199]
[200] *Determination of blood alcohol concentration
[201] - Alcohol concentration was measured with manipulation of a kit using an enzymatic bioanalysis UV-method (F-kit Roche, Cat. No. 0176290).
[202] - Alcohol is oxidized into acetaldehyde by the action of alcohol dehydrogenase
(ADH) in the presence of nicotinamide- adenine dinucleotide (NAD). When one alcohol molecule is oxidized, NAD binds to alcohol. Therefore, NAD and ADH are reacted in serum samples, and amounts of the resulting NADH are determined using a spectrophotometer.
[203]
[204] 2) Liver Function Test (LFT) (SGPT(ALT), SGOT(AST) and γ-GTP)
[205] - Levels of SGPT(ALT), SGOT(AST) and γ-GTP in the blood were respectively measured upon initial collection of blood before alcohol administration and upon final collection of blood after alcohol administration, during the first test and second test.
[206]
[207] 3) Evaluation of vital signs
[208] - For evaluation of vital signs, blood pressure, pulse rate and body temperature of subjects were respectively measured before alcohol administration and at time points of 0.5, 1, 2, 4, 6 and 15 hours after alcohol administration during the first test and second test.
[209]
[210] 4) Examination of abnormal responses
[211] - Information on abnormal responses was obtained from voluntary periodic reports of subjects and was confirmed via medical examination and treatment such as interview and history taking, which was carried out by the person in charge of this test during a test period.
[212] - Examination of subjective and objective symptoms: in order to check subjective and objective symptoms, expression of abnormal responses was investigated by medical examination of the physician in charge, and a degree of symptom expression
was recorded on the criteria of evaluation criteria. In addition, a causal relationship between the test group and alcohol administration was also assessed.
[213] [214] B. Test results and Conclusion [215] 1) Blood alcohol concentration of subjects [216] Analysis results are set forth in Table 6 and FIG. 3. The hangover cure-intake group, immediately following alcohol drinking, exhibited the blood alcohol concentration higher than that of a control (placebo) group, but the blood alcohol concentration of the hangover cure-intake group was lower than that of the control group, at all of the time points after 15 min. The time to reach the highest level of the blood alcohol concentration after alcohol consumption was 1 hour after drinking for the hangover cure-intake group and 2 hours for the control group, respectively, thus representing that the control group took a relatively longer time to reach the highest alcohol concentration, as compared to the experimental group. The alcohol concentration gradually decreased after 2 hours, and substantially no blood alcohol was detected in both groups after 15 hours. The blood alcohol concentration after alcohol consumption, which reached the highest blood level, was 79.6 mg/dL (1 hour after drinking) for the hangover cure-intake group and 98.4 mg/dL (2 hours after drinking), respectively. In addition, the blood alcohol concentration of the hangover cure-intake group was lower than that of the control group, at all of the time points with the exception of a time point immediately after drinking.
[217] [218] Table 6
Blood alcohol concentrations of a group to which the hangover cure of the present invention was administered and a control group, with respect to respective time points of blood collection after drinking
[219] SD = Standard Deviation [220] [221] 2) Examination results for liver function values of subjects
[222] Blood SGPT(ALT), SGOT(AST) and γ-GTP levels of subjects were respectively measured upon initial collection of blood before alcohol administration and upon final collection of blood after alcohol administration. The results are given in Table 7 below. As to liver function values after drinking, the control group exhibited relatively high values as compared to the hangover cure-intake group.
[223] [224] Table 7
Liver function values of a group to which the hangover cure of the present invention was administered and a control group, before and after drinking
[225] [226] 3) Frequency of hangover-related subjective symptoms [227] Generally speaking, hangover symptoms refer to various aftereffects following intake of alcoholic beverages, such as headache, diarrhea, anorexia, nausea, vomiting and the like. Therefore, after administration of alcohol into subjects, hangover symptoms were compared therebetween. From questionnaire results, it was confirmed that the control group exhibited a relatively high frequency of symptoms as compared to the hangover cure-intake group, as evident by headache (hangover cure-intake group: 1, control group: 2), vomiting (hangover cure-intake group: 0, control group: 2), asthenia (hangover cure-intake group: 0, control group: 1), and sensitivity to stimuli (hangover cure-intake group: 0, control group: 1).
[228] [229] 4) Vital signs after drinking of alcohol [230] In order to examine whether subjects exhibit abnormal responses and in order to examine aspects of vital signs of subjects after alcohol drinking, blood pressure and pulse rate of subjects were respectively measured before alcohol administration and at time points of 0.5, 1, 2, 4, 6 and 15 hours after alcohol administration during the first test and second test. According to the results thus measured, both the hangover cure- intake group and control group did not exhibit abnormal responses. Further, blood pressure began to decrease after alcohol administration, reached the lowest level at around 4 hours after alcohol intake, and thereafter gradually increased to recover to the normal state at 15 hours. Such behavior of the blood pressure was in proportion to the
blood alcohol concentration.
[231] [232] Table 8
Comparison of vital signs after alcohol consumption between the hangover cure-intake group and the control group
[233] * SD = Standard Deviation [234] *BP = Blood Pressure [235] [236] Summary of results [237] 3 people out of ten subjects, who exhibited vomiting following alcohol intake and maladjustment to the test, were excluded from the final analysis. The blood alcohol concentration of the hangover cure-intake group was lower than that of the control group, at all of the time points with the exception of a time point immediately after drinking. From comparison results of hangover symptoms after administration of alcohol into subjects, it was confirmed that the control group exhibited a higher frequency of symptoms including headache, vomiting, asthenia, and sensitivity to stimuli, as compared to the group to which the hangover cure of the present invention was administered. In order to examine whether subjects exhibit abnormal responses and in order to examine aspects of vital signs thereof after alcohol consumption, blood pressure and pulse rate of subjects were respectively measured before alcohol administration and at time points of 0.5, 1, 2, 4, 6 and 15 hours after alcohol administration during the first test and second test. According to the results thus measured, abnormal responses were not observed in both the hangover cure-intake group and control group.
Further, blood pressure began to decrease after alcohol administration, reached the lowest level at around 4 hours after alcohol intake, and thereafter gradually increased to recover to the normal state at 15 hours. Such a pattern of the blood pressure exhibited a tendency proportional to the blood alcohol concentration. In addition, similar to the raw unripe red pepper extract of Example 1, the substantially same clinical test results were also obtained for the raw ripe red pepper extract of Example 2.
[238]
[239] Example 16: Clinical Tests
[240] Using the red pepper extract obtained in Example 7 as a sample, a clinical test for hangover-relieving effects thereof on humans was carried out. The test was performed by Dept. of Preventive Medicine Yonsei Univ. Wonju College of Medicine (Wonju, Korea).
[241] The clinical test was performed in the same manner as in Example 15, except that
20 healthy adults, aged from 20 to 40 and suitable for the criteria of selection, were included in the test.
[242]
[243] Test results and Conclusion
[244] 1) Blood alcohol concentration of subjects
[245] Analysis results are set forth in Table 9 and FIG. 4. The hangover cure-intake group generally exhibited the blood alcohol concentration lower than that of a control (non-intake) group. The time to reach the highest level of the blood alcohol concentration after alcohol consumption was 2 hours after drinking for the hangover cure- intake group and 1 hour for the control group, respectively, thus representing that the hangover cure-intake group took a relatively longer time to reach the highest alcohol concentration. The alcohol concentration gradually decreased after 2 hours, and substantially no blood alcohol was detected in both groups after 15 hours. The blood alcohol concentration after alcohol consumption, which reached the highest blood level, was 99.56 mg/dL (2 hours after drinking) for the hangover cure-intake group and 111.6 mg/dL (1 hour after drinking), respectively. In addition, the blood alcohol concentration of the hangover cure-intake group was lower than that of the control group, at all of the time points.
[246]
[247] Table 9
Blood alcohol concentrations of a group to which the hangover cure of the present invention was administered and a control group, with respect to respective time points of blood collection after drinking (Unit: mg/dL)
[248] * SD = Standard Deviation [249] [250] 2) Examination results for liver function values of subjects [251] Blood SGPT(ALT), SGOT(AST) and γ-GTP levels of subjects were respectively measured upon initial collection of blood before alcohol administration and upon final collection of blood after alcohol administration. The results are given in Table 10 below. As to liver function values after drinking, the control group exhibited relatively high values as compared to the hangover cure-intake group.
[252] [253] Table 10
Liver function values of a group to which the hangover cure of the present invention was administered and a control group, before and after drinking (Unit:mg/dL)
[254] [255] 3) Frequency of hangover-related subjective symptoms [256] Generally speaking, hangover symptoms refer to various aftereffects following intake of alcoholic beverages, such as headache, diarrhea, anorexia, nausea, vomiting and the like. Therefore, after administration of alcohol into subjects, hangover symptoms were compared therebetween. From questionnaire results, it was confirmed that the control group exhibited a relatively high frequency of symptoms as compared to the hangover cure-intake group, as evident by asthenia (hangover cure-intake group: 2, control group: 4), sensitivity to stimuli (hangover cure-intake group: 0, control group: 2), sticky sweat (hangover cure-intake group: 0, control group: 2), and memory blackout (hangover cure-intake group: 0, control group: 2).
[257] [258] 4) Vital signs after drinking of alcohol [259] In order to examine whether subjects exhibit abnormal responses and in order to examine aspects of vital signs of subjects after alcohol drinking, blood pressure and pulse rate of subjects were respectively measured before alcohol administration and at time points of 0.5, 1, 2, 4, 6 and 15 hours after alcohol administration during the first test and second test. According to the results thus measured, both the hangover cure- intake group and control group did not exhibit abnormal responses. Further, blood pressure began to decrease after alcohol administration, reached the lowest level at around 4 hours after alcohol intake, and thereafter gradually increased to recover to the normal state at 15 hours. Such behavior of the blood pressure was in proportion to the blood alcohol concentration.
[260] [261] Table 11
Comparison of vital signs after alcohol consumption between the hangover cure-intake group and the control group
[263] *BP = Blood Pressure
[264]
[265] Summary of results
[266] The final analysis was carried out for twenty subjects. The blood alcohol concentration of the hangover cure-intake group was lower than that of the control group, at all of the time points. In particular, the blood alcohol concentration of the hangover cure-intake group was low up to one hour after alcohol consumption. From comparison results of hangover symptoms after administration of alcohol into subjects, it was confirmed that the control group exhibited a higher frequency of symptoms including asthenia, sensitivity to stimuli, sticky sweat, and memory blackout, as compared to the group to which the hangover cure of the present invention was administered. In order to examine whether subjects exhibit abnormal responses and in order to examine aspects of vital signs thereof after alcohol consumption, the blood pressure and pulse rate of subjects were respectively measured before alcohol administration and at time points of 0.5, 1, 2, 4, 6 and 15 hours after alcohol administration during the first test and second test. According to the results thus measured, abnormal responses were not observed in both the hangover cure-intake group and control group. Further, the blood pressure began to decrease after alcohol administration, reached the lowest level at around 4 hours after alcohol intake, and thereafter gradually increased to recover to the normal state at 15 hours. Such a pattern of the blood pressure exhibited a tendency proportional to the blood alcohol concentration. In addition, similar to the raw unripe red pepper extract of Example 7, the substantially same clinical test results were also obtained for the raw ripe red pepper extract of Example 8.
[267]
[268] Example 17: Preparation of beverage
[269] The red pepper extract obtained in Example 1 or 2, or Example 7 or 8 may be used directly as a beverage, or may be otherwise prepared into a beverage form via combination with other beverage components. When the red pepper extract per se is used as a beverage for relieving hangover, 20 mL of the extract can be administered as a single dose or in two divided doses, before and/or after alcohol drinking.
[270]
[271] Preparative Example 1
[272] A beverage was prepared by adding 10% by weight of the raw unripe red pepper extract obtained in Example 1 to a common orange juice.
[273]
[274] Preparative Example 2
[275] A beverage was prepared by mixing 20% by weight of the raw unripe red pepper
extract obtained in Example 1 and 80% by weight of water.
[276]
[277] Preparative Example 3
[278] A beverage was prepared by adding 15% by weight of the raw ripe red pepper extract obtained in Example 2 to a common apple juice.
[279]
[280] Preparative Example 4
[281] A beverage was prepared by mixing 12% by weight of the raw ripe red pepper extract obtained in Example 2 and 88% by weight of water.
[282]
[283] Preparative Example 5
[284] A beverage was prepared by adding 10% by weight of the raw unripe red pepper extract obtained in Example 7 to a common orange juice.
[285]
[286] Preparative Example 6
[287] A beverage was prepared by mixing 20% by weight of the raw unripe red pepper extract obtained in Example 7 and 80% by weight of water.
[288]
[289] Preparative Example 7
[290] A beverage was prepared by adding 15% by weight of the raw ripe red pepper extract obtained in Example 8 to a common apple juice.
[291]
[292] Preparative Example 8
[293] A beverage was prepared by mixing 12% by weight of the raw ripe red pepper extract obtained in Example 8 and 88% by weight of water.
[294]
[295] Although the preferred embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that various modifications, additions and substitutions are possible, without departing from the scope and spirit of the invention as disclosed in the accompanying claims.
Claims
[1] A hangover cure comprising, as an active ingredient, a red pepper extract obtained by squeezing the juice of raw red peppers, followed by distillation.
[2] The hangover cure according to claim 1, wherein the red pepper extract is in the form of transparent liquid and is obtained by an extraction process comprising: washing raw red peppers with water and dehydrating the washed materials to remove moisture; squeezing the juice of red peppers in a press fashion; and heating the squeezed juice to 50 to 11O0C, passing the resulting steam through a cooling device to collect the condensed liquid, and subjecting the distilled and condensed liquid to filtration under reduced pressure.
[3] The hangover cure according to claim 1, wherein the raw red pepper extract is in the form of transparent liquid and is obtained by an extraction process comprising: washing raw unripe red peppers with water and dehydrating the washed materials to remove moisture; squeezing the juice of red peppers in a press fashion; heating the squeezed juice with stirring at a temperature of 90 to 11O0C until no bubbles are formed; cooling the heated juice at room temperature for 3 to 4 hours, thereby separating the juice into a top layer of a liquid phase and a bottom layer of aggregates, and collecting the liquid layer therefrom; heating the liquid layer fraction to 70 to 1150C and passing the resulting steam through a cooling device, followed by collecting the condensed liquid; and subjecting the distilled and condensed liquid to filtration under reduced pressure.
[4] The hangover cure according to any one of claims 1 to 3, wherein the raw red pepper is a raw unripe red pepper or a raw ripe red pepper.
[5] The hangover cure according to claim 1, further comprising 0.5 to 5% by weight of pyroligneous liquor, based on the total weight of the hangover cure.
[6] The hangover cure according to claim 5, wherein the pyroligneous liquor comprises 2 to 4% by weight of acetic acid, 0.05 to 0.15% by weight of formic acid, 0.05 to 0.15% by weight of propionic acid, 1 to 3% by weight of mugwort components, 0.01 to 1% by weight of sodium acetate (or zinc sulfate) and the balance of purified water.
[7] The hangover cure according to claim 1, further comprising 0.5 to 10% by weight of a garlic extract, based on the total weight of the hangover cure.
[8] The hangover cure according to claim 1, wherein the hangover cure is composed of 2 to 100% by weight of the raw red pepper extract and the balance of purified water.
[9] The hangover cure according to claim 1, wherein the hangover cure is in the form of a capsule, a tablet or a health drink.
[10] A health food having hangover-relieving effects by containing the hangover cure of any one of claims 1 to 3 as an active ingredient. [11] The food according to claim 10, wherein the health food is selected from the group consisting of tea, jelly, sap, juice, extract, beverage and favorite foods. [12] The food according to claim 10, wherein the hangover cure is contained in the range of 0.1 to 20% by weight.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2005-0111349 | 2005-11-21 | ||
KR20050111349 | 2005-11-21 | ||
KR1020060031912A KR100642523B1 (en) | 2005-11-21 | 2006-04-07 | Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same |
KR10-2006-0031912 | 2006-04-07 | ||
KR10-2006-0089849 | 2006-09-15 | ||
KR1020060089849A KR20070108321A (en) | 2005-11-21 | 2006-09-15 | Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same |
KR1020060113201A KR100789000B1 (en) | 2005-11-21 | 2006-11-16 | Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same |
KR10-2006-0113201 | 2006-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007058505A1 true WO2007058505A1 (en) | 2007-05-24 |
Family
ID=38048852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2006/004871 WO2007058505A1 (en) | 2005-11-21 | 2006-11-20 | Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007058505A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009138844A2 (en) | 2008-05-13 | 2009-11-19 | Marco Celotti | Drink and relative preparation process |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950024764A (en) * | 1994-02-18 | 1995-09-15 | 강상모 | Alcoholic Disorder Protectors And How To Use Him |
JPH10158183A (en) * | 1996-11-26 | 1998-06-16 | Wakunaga Pharmaceut Co Ltd | Composition for preventing and treating hangover |
EP0878199A1 (en) * | 1996-11-07 | 1998-11-18 | Jong Hyun Nam | Natural teas for taking off the effects of drink and process for the production thereof |
KR20030084666A (en) * | 2002-04-22 | 2003-11-01 | 조아제약주식회사 | A functional beverage composition |
KR20050115477A (en) * | 2004-06-03 | 2005-12-08 | 박무호 | Hot pepper extracts made form pressing hot pepper |
-
2006
- 2006-11-20 WO PCT/KR2006/004871 patent/WO2007058505A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950024764A (en) * | 1994-02-18 | 1995-09-15 | 강상모 | Alcoholic Disorder Protectors And How To Use Him |
EP0878199A1 (en) * | 1996-11-07 | 1998-11-18 | Jong Hyun Nam | Natural teas for taking off the effects of drink and process for the production thereof |
JPH10158183A (en) * | 1996-11-26 | 1998-06-16 | Wakunaga Pharmaceut Co Ltd | Composition for preventing and treating hangover |
KR20030084666A (en) * | 2002-04-22 | 2003-11-01 | 조아제약주식회사 | A functional beverage composition |
KR20050115477A (en) * | 2004-06-03 | 2005-12-08 | 박무호 | Hot pepper extracts made form pressing hot pepper |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009138844A2 (en) | 2008-05-13 | 2009-11-19 | Marco Celotti | Drink and relative preparation process |
WO2009138844A3 (en) * | 2008-05-13 | 2010-02-25 | Marco Celotti | Drink and process for preparing said drink |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5230431B2 (en) | Method for lowering blood pressure in individuals with prehypertension and / or individuals with metabolic syndrome | |
KR20140085786A (en) | Vinegar beberage using jujube and fruit juice | |
CN110876258B (en) | Beetroot juice for improving intestinal absorption rate, its preparation method and application | |
KR100852416B1 (en) | Cucurbitaceae vinegar composition | |
CN108835638A (en) | A kind of Soboring-up liver-protecting improves the food and preparation method thereof of immunity | |
JPH08225453A (en) | Lipoprotein (a) depressor, cholesterol depressor and medicine containing the same | |
JP2006193502A (en) | Adiponectin regulating agent and food, drink, food additive and medicine containing the same | |
KR20080030844A (en) | Composition for prevention of obesity containing a hot pepper extract and health supporting foods containing the same | |
KR101394358B1 (en) | Health composition relieving alcohol hangover | |
KR20070108321A (en) | Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same | |
KR101808586B1 (en) | Manufacturing method of high purity black garlic concentrate removed oils extracts | |
CN108077433A (en) | The preparation method of Hippophae Rhamnoides L. juice Yoghourt | |
KR20210012982A (en) | Method of manufacturing mulberry leaf extract using lactic acid bacteria fermentation, and mulberry leaf extract manufactured by the method | |
KR100789000B1 (en) | Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same | |
TWI627962B (en) | Composition for improving blood glucose metabolism | |
CN114304609B (en) | Rose ferment with lipid-lowering effect and preparation method thereof | |
WO2007058505A1 (en) | Hangover curing agent containing a raw unripe red pepper extract and health supporting foods containing the same | |
CN109280589A (en) | One kind zero adds health grain wine method of making liquor | |
CN109480136A (en) | A kind of roxburgh rose beverage and preparation method thereof | |
CN108125081A (en) | A kind of fragrant and sweet type beverage made of fruits or vegetables of passion fruit and preparation process | |
JP2004238289A (en) | Thrombogenic inhibitor and functional food | |
Gallo et al. | An overview of natural beverages | |
KR100929337B1 (en) | Extraction method of red pepper extract for hangover | |
WO2006064761A1 (en) | Adiponectin regultor and foods, drinks, food aditives and drugs containing the same | |
JP2006193501A (en) | Adiponectin regulating agent and food, drink, food additive and medicine containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06812642 Country of ref document: EP Kind code of ref document: A1 |